Rampart Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-545
Closed -$214K 177
2020
Q3
$214K Sell
545
-1,062
-66% -$393K 0.14% 162
2020
Q2
$531K Buy
1,607
+897
+126% +$260K 0.09% 245
2020
Q1
$172K Sell
710
-790
-53% -$206K 0.08% 216
2019
Q4
$392K Sell
1,500
-18
-1% -$4.74K 0.05% 353
2019
Q3
$413K Sell
1,518
-90
-6% -$25K 0.05% 331
2019
Q2
$443K Sell
1,608
-108
-6% -$26.6K 0.05% 335
2019
Q1
$384K Buy
1,716
+791
+86% +$163K 0.04% 356
2018
Q4
$172K Sell
925
-2,744
-75% -$563K 0.05% 294
2018
Q3
$241K Sell
3,669
-1,145
-24% -$278K 0.11% 211
2018
Q2
$1.05M Buy
4,814
+1,171
+32% +$241K 0.1% 261
2018
Q1
$697K Buy
3,643
+2,559
+236% +$472K 0.07% 292
2017
Q4
$170K Sell
1,084
-160
-13% -$25.2K 0.07% 317
2017
Q3
$193K Buy
1,244
+79
+7% +$12.5K 0.07% 307
2017
Q2
$188K Buy
1,165
+917
+370% +$149K 0.07% 310
2017
Q1
$38K Buy
+248
New +$34.2K 0.01% 323

Other funds holding IDXX

Rampart Investment Management's IDXX Position: Q4 2020 in Review

Rampart Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 545 shares — an estimated $214K sold.

Rampart Investment Management first reported a position in IDXX in Q1 2017 and held it in 15 quarters. The position peaked at $1.05M in Q2 2018. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Rampart Investment Management reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 545 Idexx Laboratories shares in Q4 2020, an estimated $214K.
  • Rampart Investment Management first reported a position in Idexx Laboratories in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Idexx Laboratories position peaked at $1.05M in Q2 2018.
  • 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.